SuspendedEarly Phase 1

Lipografting Versus Steroid Injections for Treatment of Carpal Tunnel Syndrome

Stopped: lack of funding

United States100 participantsStarted 2016-12-19

Plain-language summary

This study applies the regenerative properties of autologous fat transfer to treat mild to moderate carpal tunnel syndrome in comparison to the current standard of care, corticosteroid treatment. The investigators hypothesize the fat transfer would prevent scar formation and aid in nerve excursion along the canal (while the neoangiogenic and regenerative growth factors could stimulate nerve regeneration) better than the standard of care treatment.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * primary mild to moderate carpal tunnel syndrome (CTS) * report symptoms longer than 6 months * night pain * weakness * sensory deficits * fluent English-speaking adult (\>18) Exclusion Criteria: * \<18 years old * Non-english speaking * injection in past 6 months * previous hand surgery * previous hand trauma (fracture or dislocation)

What they're measuring

Functional Outcome Score

Timeframe: Up to 1 year post-treatment

Trial details

NCT IDNCT03722303

SponsorColumbia University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-12

View on ClinicalTrials.gov More Carpal Tunnel Syndrome trials